Literature DB >> 2713345

Purification and determination of the NH2-terminal amino acid sequence of uracil-DNA glycosylase from human placenta.

C U Wittwer1, G Bauw, H E Krokan.   

Abstract

Uracil-DNA glycosylase has been purified approximately 130,000-fold from extracts of human placenta. Although all of the uracil-DNA glycosylase activity coeluted through six chromatographic steps, at least four distinct peaks of activity were resolved in the final purification on a Mono S column. Each of the peaks containing uracil-DNA glycosylase activity contained two peptides of Mr = 29,000 and Mr = 26,500, respectively, as analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Experimental evidence indicated that the Mr = 29,000 peptide was the uracil-DNA glycosylase enzyme. The amino-terminal sequence of each peptide was determined after blotting of the peptides from the gel onto Polybrene GF/C paper. The sequences were not related to each other, and neither was any significant homology to other proteins found. Uracil-DNA glycosylase had a molecular turnover number of approximately 600/min and apparent Km value of 2 microM. The enzyme is a basic protein and was stimulated about 10-fold by 60-70 mM NaCl whereas higher concentrations were inhibitory.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713345     DOI: 10.1021/bi00428a055

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene.

Authors:  H Nilsen; M Otterlei; T Haug; K Solum; T A Nagelhus; F Skorpen; H E Krokan
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

2.  Mechanism of incision by an apurinic/apyrimidinic endonuclease present in human placenta.

Authors:  B I Haukanes; C U Wittwer; D E Helland
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

3.  Isolation and characterization of the human uracil DNA glycosylase gene.

Authors:  T M Vollberg; K M Siegler; B L Cool; M A Sirover
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Repair of chromosomal abasic sites in vivo involves at least three different repair pathways.

Authors:  M Otterlei; B Kavli; R Standal; C Skjelbred; S Bharati; H E Krokan
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

5.  Cell cycle regulation and in vitro hybrid arrest analysis of the major human uracil-DNA glycosylase.

Authors:  G Slupphaug; L C Olsen; D Helland; R Aasland; H E Krokan
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

6.  Human uracil-DNA glycosylase complements E. coli ung mutants.

Authors:  L C Olsen; R Aasland; H E Krokan; D E Helland
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

7.  Nuclear and mitochondrial forms of human uracil-DNA glycosylase are encoded by the same gene.

Authors:  G Slupphaug; F H Markussen; L C Olsen; R Aasland; N Aarsaether; O Bakke; H E Krokan; D E Helland
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

8.  Consensus sequences for good and poor removal of uracil from double stranded DNA by uracil-DNA glycosylase.

Authors:  I Eftedal; P H Guddal; G Slupphaug; G Volden; H E Krokan
Journal:  Nucleic Acids Res       Date:  1993-05-11       Impact factor: 16.971

9.  B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil.

Authors:  Bodil Kavli; Sonja Andersen; Marit Otterlei; Nina B Liabakk; Kohsuke Imai; Alain Fischer; Anne Durandy; Hans E Krokan; Geir Slupphaug
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

10.  Molecular cloning of human uracil-DNA glycosylase, a highly conserved DNA repair enzyme.

Authors:  L C Olsen; R Aasland; C U Wittwer; H E Krokan; D E Helland
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.